2025-05-02 |
2025-05-01 |
PS
Planned sale
|
Chapman Steven Leonard
CEO AND PRESIDENT
Executive Director
|
1,000
-0.4%
152.04
USD 117,071
|
1,000
-0.4%
|
152.04
|
USD 100,000
|
|
2025-05-02 |
2025-05-01 |
PS
Planned sale
|
Chapman Steven Leonard
CEO AND PRESIDENT
Executive Director
|
1,000
-1.2%
151.26
USD 330,665
|
1,000
-1.2%
|
151.26
|
USD 100,000
|
|
2025-05-02 |
2025-05-01 |
PS
Planned sale
|
Chapman Steven Leonard
CEO AND PRESIDENT
Executive Director
|
1,000
-1.1%
149.94
USD 302,130
|
1,000
-1.1%
|
149.94
|
USD 100,000
|
|
2025-05-02 |
2025-05-01 |
PS
Planned sale
|
Chapman Steven Leonard
CEO AND PRESIDENT
Executive Director
|
1,000
-1.0%
148.25
USD 297,837
|
1,000
-1.0%
|
148.25
|
USD 100,000
|
|
2025-05-02 |
2025-05-01 |
PS
Planned sale
|
Marcus Gail Boxer
Non-Executive Director
|
1,000
-13.0%
153.06
USD 221,941
|
1,000
-13.0%
|
153.06
|
USD 100,000
|
|
2025-05-02 |
2025-05-01 |
PS
Planned sale
|
Marcus Gail Boxer
Non-Executive Director
|
1,000
-7.8%
152.22
USD 143,392
|
1,000
-7.8%
|
152.22
|
USD 100,000
|
|
2025-05-02 |
2025-05-01 |
PS
Planned sale
|
Marcus Gail Boxer
Non-Executive Director
|
1,000
-5.3%
151.37
USD 101,719
|
1,000
-5.3%
|
151.37
|
USD 100,000
|
|
2025-05-02 |
2025-05-01 |
PS
Planned sale
|
Marcus Gail Boxer
Non-Executive Director
|
1,000
-2.6%
149.96
USD 51,138
|
1,000
-2.6%
|
149.96
|
USD 100,000
|
|
2025-05-02 |
2025-05-01 |
PS
Planned sale
|
Marcus Gail Boxer
Non-Executive Director
|
1,000
-1.8%
149.05
USD 35,920
|
1,000
-1.8%
|
149.05
|
USD 100,000
|
|
2025-05-02 |
2025-05-01 |
PS
Planned sale
|
Marcus Gail Boxer
Non-Executive Director
|
1,000
-2.4%
147.95
USD 47,787
|
1,000
-2.4%
|
147.95
|
USD 100,000
|
|
2025-05-02 |
2025-05-01 |
PS
Planned sale
|
Marcus Gail Boxer
Non-Executive Director
|
1,000
-0.2%
146.34
USD 4,537
|
1,000
-0.2%
|
146.34
|
USD 100,000
|
|
2025-05-02 |
2025-05-01 |
PS
Planned sale
|
Moshkevich Solomon
PRESIDENT, CLINICALDIAGNOSTICS
Officer
|
1,000
-0.2%
152.04
USD 50,325
|
1,000
-0.2%
|
152.04
|
USD 100,000
|
|
2025-05-02 |
2025-05-01 |
PS
Planned sale
|
Moshkevich Solomon
PRESIDENT, CLINICALDIAGNOSTICS
Officer
|
1,000
-0.7%
151.30
USD 137,379
|
1,000
-0.7%
|
151.30
|
USD 100,000
|
|
2025-05-02 |
2025-05-01 |
PS
Planned sale
|
Moshkevich Solomon
PRESIDENT, CLINICALDIAGNOSTICS
Officer
|
1,000
-0.7%
149.99
USD 136,188
|
1,000
-0.7%
|
149.99
|
USD 100,000
|
|
2025-05-02 |
2025-05-01 |
PS
Planned sale
|
Moshkevich Solomon
PRESIDENT, CLINICALDIAGNOSTICS
Officer
|
1,000
-0.6%
148.25
USD 126,460
|
1,000
-0.6%
|
148.25
|
USD 100,000
|
|
2025-04-30 |
2025-04-29 |
PS
Planned sale
|
Brophy Michael Burkes
CHIEF FINANCIAL OFFICER
Officer
|
1,000
-0.3%
155.44
USD 31,087
|
1,000
-0.3%
|
155.44
|
USD 100,000
|
|
2025-04-30 |
2025-04-29 |
PS
Planned sale
|
Brophy Michael Burkes
CHIEF FINANCIAL OFFICER
Officer
|
1,000
-2.0%
154.74
USD 223,605
|
1,000
-2.0%
|
154.74
|
USD 100,000
|
|
2025-04-30 |
2025-04-29 |
PS
Planned sale
|
Brophy Michael Burkes
CHIEF FINANCIAL OFFICER
Officer
|
1,000
-1.0%
153.94
USD 107,761
|
1,000
-1.0%
|
153.94
|
USD 100,000
|
|
2025-04-30 |
2025-04-29 |
PS
Planned sale
|
Brophy Michael Burkes
CHIEF FINANCIAL OFFICER
Officer
|
1,000
-1.0%
152.90
USD 107,030
|
1,000
-1.0%
|
152.90
|
USD 100,000
|
|
2025-04-30 |
2025-04-28 |
PS
Planned sale
|
Chapman Steven Leonard
CEO AND PRESIDENT
Executive Director
|
1,000
-3.1%
152.18
USD 943,987
|
1,000
-3.1%
|
152.18
|
USD 100,000
|
|
2025-04-30 |
2025-04-28 |
PS
Planned sale
|
Fesko John
PRESIDENT, CHIEF BUS. OFFICER
Officer
|
1,709
-1.1%
152.18
USD 260,080
|
1,709
-1.1%
|
152.18
|
USD 260,080
|
|
2025-04-30 |
2025-04-28 |
PS
Planned sale
|
Rabinowitz Matthew
EXECUTIVE CHAIRMAN
Executive Director
|
1,718
-0.1%
152.18
USD 261,449
|
1,718
-0.1%
|
152.18
|
USD 261,449
|
|
2025-04-30 |
2025-04-28 |
PS
Planned sale
|
Sheena Jonathan
Non-Executive Director
|
439
-0.2%
152.18
USD 66,808
|
439
-0.2%
|
152.18
|
USD 66,808
|
|
2025-04-30 |
2025-04-28 |
PS
Planned sale
|
Brophy Michael Burkes
CHIEF FINANCIAL OFFICER
Officer
|
2,018
-2.7%
152.18
USD 307,104
|
2,018
-2.7%
|
152.18
|
USD 307,104
|
|
2025-04-30 |
2025-04-28 |
PS
Planned sale
|
RABINOWITZ DANIEL
SEC. AND CHIEF LEGAL OFFICER
Officer
|
1,993
-0.9%
152.18
USD 303,300
|
1,993
-0.9%
|
152.18
|
USD 303,300
|
|
2025-04-30 |
2025-04-28 |
PS
Planned sale
|
Moshkevich Solomon
PRESIDENT, CLINICALDIAGNOSTICS
Officer
|
2,206
-1.6%
152.18
USD 335,714
|
2,206
-1.6%
|
152.18
|
USD 335,714
|
|
2025-04-24 |
2025-04-24 |
PS
Planned sale
|
Brophy Michael Burkes
CHIEF FINANCIAL OFFICER
Officer
|
194
-0.3%
152.46
USD 29,577
|
194
-0.3%
|
152.46
|
USD 29,577
|
|
2025-04-24 |
2025-04-24 |
PS
Planned sale
|
Brophy Michael Burkes
CHIEF FINANCIAL OFFICER
Officer
|
561
-0.7%
152.45
USD 85,524
|
561
-0.7%
|
152.45
|
USD 85,524
|
|
2025-04-24 |
2025-04-23 |
PS
Planned sale
|
Brophy Michael Burkes
CHIEF FINANCIAL OFFICER
Officer
|
495
-0.6%
150.74
USD 74,616
|
495
-0.6%
|
150.74
|
USD 74,616
|
|
2025-04-24 |
2025-04-22 |
PS
Planned sale
|
Brophy Michael Burkes
CHIEF FINANCIAL OFFICER
Officer
|
603
-0.8%
145.35
USD 87,645
|
603
-0.8%
|
145.35
|
USD 87,645
|
|
2025-04-24 |
2025-04-22 |
PS
Planned sale
|
Brophy Michael Burkes
CHIEF FINANCIAL OFFICER
Officer
|
308
-0.4%
144.30
USD 44,446
|
308
-0.4%
|
144.30
|
USD 44,446
|
|
2025-04-22 |
2025-04-21 |
PS
Planned sale
|
Fesko John
PRESIDENT, CHIEF BUS. OFFICER
Officer
|
4
-0.0%
146.10
USD 584
|
4
-0.0%
|
146.10
|
USD 584
|
|
2025-04-22 |
2025-04-21 |
PS
Planned sale
|
Fesko John
PRESIDENT, CHIEF BUS. OFFICER
Officer
|
339
-0.2%
145.54
USD 49,338
|
339
-0.2%
|
145.54
|
USD 49,338
|
|
2025-04-22 |
2025-04-21 |
PS
Planned sale
|
Sheena Jonathan
Non-Executive Director
|
1
-0.0%
146.16
USD 146
|
1
-0.0%
|
146.16
|
USD 146
|
|
2025-04-22 |
2025-04-21 |
PS
Planned sale
|
Sheena Jonathan
Non-Executive Director
|
85
-0.0%
145.54
USD 12,371
|
85
-0.0%
|
145.54
|
USD 12,371
|
|
2025-04-22 |
2025-04-21 |
PS
Planned sale
|
Moshkevich Solomon
PRESIDENT, CLINICALDIAGNOSTICS
Officer
|
4
-0.0%
146.85
USD 587
|
4
-0.0%
|
146.85
|
USD 587
|
|
2025-04-22 |
2025-04-21 |
PS
Planned sale
|
Moshkevich Solomon
PRESIDENT, CLINICALDIAGNOSTICS
Officer
|
292
-0.2%
145.54
USD 42,498
|
292
-0.2%
|
145.54
|
USD 42,498
|
|
2025-04-22 |
2025-04-21 |
PS
Planned sale
|
Brophy Michael Burkes
CHIEF FINANCIAL OFFICER
Officer
|
8
-0.0%
146.16
USD 1,169
|
8
-0.0%
|
146.16
|
USD 1,169
|
|
2025-04-22 |
2025-04-21 |
PS
Planned sale
|
Brophy Michael Burkes
CHIEF FINANCIAL OFFICER
Officer
|
602
-0.8%
145.54
USD 87,615
|
602
-0.8%
|
145.54
|
USD 87,615
|
|
2025-04-22 |
2025-04-21 |
PS
Planned sale
|
RABINOWITZ DANIEL
SEC. AND CHIEF LEGAL OFFICER
Officer
|
6
-0.0%
146.16
USD 877
|
6
-0.0%
|
146.16
|
USD 877
|
|
2025-04-22 |
2025-04-21 |
PS
Planned sale
|
RABINOWITZ DANIEL
SEC. AND CHIEF LEGAL OFFICER
Officer
|
464
-0.2%
145.54
USD 67,531
|
464
-0.2%
|
145.54
|
USD 67,531
|
|
2025-04-22 |
2025-04-21 |
PS
Planned sale
|
Chapman Steven Leonard
CEO AND PRESIDENT
Executive Director
|
21
-0.0%
146.07
USD 3,067
|
21
-0.0%
|
146.07
|
USD 3,067
|
|
2025-04-22 |
2025-04-21 |
PS
Planned sale
|
Chapman Steven Leonard
CEO AND PRESIDENT
Executive Director
|
1,643
-0.8%
145.54
USD 239,122
|
1,643
-0.8%
|
145.54
|
USD 239,122
|
|
2025-04-04 |
2025-04-04 |
PS
Planned sale
|
Sheena Jonathan
Non-Executive Director
|
100
-0.0%
136.05
USD 13,605
|
100
-0.0%
|
136.05
|
USD 13,605
|
|
2025-04-04 |
2025-04-04 |
PS
Planned sale
|
Sheena Jonathan
Non-Executive Director
|
300
-0.1%
135.24
USD 40,573
|
300
-0.1%
|
135.24
|
USD 40,573
|
|
2025-04-04 |
2025-04-04 |
PS
Planned sale
|
Sheena Jonathan
Non-Executive Director
|
400
-0.2%
133.86
USD 53,544
|
400
-0.2%
|
133.86
|
USD 53,544
|
|
2025-04-04 |
2025-04-04 |
PS
Planned sale
|
Sheena Jonathan
Non-Executive Director
|
1,050
-0.4%
133.28
USD 139,939
|
1,050
-0.4%
|
133.28
|
USD 139,939
|
|
2025-04-04 |
2025-04-04 |
PS
Planned sale
|
Sheena Jonathan
Non-Executive Director
|
1,220
-0.5%
132.04
USD 161,091
|
1,220
-0.5%
|
132.04
|
USD 161,091
|
|
2025-04-04 |
2025-04-03 |
PS
Planned sale
|
Sheena Jonathan
Non-Executive Director
|
355
-0.9%
140.94
USD 50,034
|
355
-0.9%
|
140.94
|
USD 50,034
|
|
2025-04-04 |
2025-04-03 |
PS
Planned sale
|
Sheena Jonathan
Non-Executive Director
|
395
-1.0%
140.00
USD 55,301
|
395
-1.0%
|
140.00
|
USD 55,301
|
|
2025-04-04 |
2025-04-03 |
PS
Planned sale
|
Sheena Jonathan
Non-Executive Director
|
490
-1.2%
138.55
USD 67,889
|
490
-1.2%
|
138.55
|
USD 67,889
|
|
2025-04-04 |
2025-04-03 |
PS
Planned sale
|
Sheena Jonathan
Non-Executive Director
|
260
-0.6%
137.08
USD 35,641
|
260
-0.6%
|
137.08
|
USD 35,641
|
|
2025-04-04 |
2025-04-03 |
PS
Planned sale
|
Sheena Jonathan
Non-Executive Director
|
100
-0.2%
141.28
USD 14,128
|
100
-0.2%
|
141.28
|
USD 14,128
|
|
2025-04-04 |
2025-04-03 |
PS
Planned sale
|
Sheena Jonathan
Non-Executive Director
|
287
-0.7%
140.57
USD 40,343
|
287
-0.7%
|
140.57
|
USD 40,343
|
|
2025-04-04 |
2025-04-03 |
PS
Planned sale
|
Sheena Jonathan
Non-Executive Director
|
396
-1.0%
139.56
USD 55,265
|
396
-1.0%
|
139.56
|
USD 55,265
|
|
2025-04-04 |
2025-04-03 |
PS
Planned sale
|
Sheena Jonathan
Non-Executive Director
|
477
-1.1%
138.57
USD 66,097
|
477
-1.1%
|
138.57
|
USD 66,097
|
|
2025-04-04 |
2025-04-03 |
PS
Planned sale
|
Sheena Jonathan
Non-Executive Director
|
240
-0.6%
136.99
USD 32,876
|
240
-0.6%
|
136.99
|
USD 32,876
|
|
2025-04-03 |
2025-04-01 |
PS
Planned sale
|
Marcus Gail Boxer
Non-Executive Director
|
197
-2.0%
142.82
USD 28,136
|
197
-2.0%
|
142.82
|
USD 28,136
|
|
2025-04-03 |
2025-04-01 |
PS
Planned sale
|
Marcus Gail Boxer
Non-Executive Director
|
365
-3.6%
142.25
USD 51,923
|
365
-3.6%
|
142.25
|
USD 51,923
|
|
2025-04-03 |
2025-04-01 |
PS
Planned sale
|
Marcus Gail Boxer
Non-Executive Director
|
1,528
-13.0%
141.13
USD 215,644
|
1,528
-13.0%
|
141.13
|
USD 215,644
|
|
2025-04-03 |
2025-04-01 |
PS
Planned sale
|
Marcus Gail Boxer
Non-Executive Director
|
1,512
-11.4%
140.17
USD 211,944
|
1,512
-11.4%
|
140.17
|
USD 211,944
|
|
2025-04-03 |
2025-04-01 |
PS
Planned sale
|
Marcus Gail Boxer
Non-Executive Director
|
398
-2.9%
139.33
USD 55,455
|
398
-2.9%
|
139.33
|
USD 55,455
|
|
2025-04-03 |
2025-04-01 |
PS
Planned sale
|
Moshkevich Solomon
PRESIDENT, CLINICALDIAGNOSTICS
Officer
|
439
-0.3%
141.90
USD 62,294
|
439
-0.3%
|
141.90
|
USD 62,294
|
|
2025-04-03 |
2025-04-01 |
PS
Planned sale
|
Moshkevich Solomon
PRESIDENT, CLINICALDIAGNOSTICS
Officer
|
1,270
-0.9%
140.70
USD 178,684
|
1,270
-0.9%
|
140.70
|
USD 178,684
|
|
2025-04-03 |
2025-04-01 |
PS
Planned sale
|
Moshkevich Solomon
PRESIDENT, CLINICALDIAGNOSTICS
Officer
|
1,291
-0.9%
139.78
USD 180,450
|
1,291
-0.9%
|
139.78
|
USD 180,450
|
|
2025-04-01 |
2025-04-01 |
PS
Planned sale
|
Chapman Steven Leonard
CEO AND PRESIDENT
Executive Director
|
1,334
-0.7%
142.28
USD 189,801
|
1,334
-0.7%
|
142.28
|
USD 189,801
|
|
2025-04-01 |
2025-04-01 |
PS
Planned sale
|
Chapman Steven Leonard
CEO AND PRESIDENT
Executive Director
|
4,022
-2.0%
141.11
USD 567,557
|
4,022
-2.0%
|
141.11
|
USD 567,557
|
|
2025-04-01 |
2025-04-01 |
PS
Planned sale
|
Chapman Steven Leonard
CEO AND PRESIDENT
Executive Director
|
8,027
-3.8%
140.20
USD 1,125,400
|
8,027
-3.8%
|
140.20
|
USD 1,125,400
|
|
2025-04-01 |
2025-04-01 |
PS
Planned sale
|
Chapman Steven Leonard
CEO AND PRESIDENT
Executive Director
|
2,515
-1.2%
139.39
USD 350,572
|
2,515
-1.2%
|
139.39
|
USD 350,572
|
|
2025-04-01 |
2025-03-31 |
PS
Planned sale
|
Brophy Michael Burkes
CHIEF FINANCIAL OFFICER
Officer
|
68
-0.1%
138.36
USD 9,408
|
68
-0.1%
|
138.36
|
USD 9,408
|
|
2025-04-01 |
2025-03-31 |
PS
Planned sale
|
Brophy Michael Burkes
CHIEF FINANCIAL OFFICER
Officer
|
2,494
-3.2%
138.41
USD 345,195
|
2,494
-3.2%
|
138.41
|
USD 345,195
|
|
2025-04-01 |
2025-03-31 |
PS
Planned sale
|
Chapman Steven Leonard
CEO AND PRESIDENT
Executive Director
|
252
-0.1%
138.42
USD 34,881
|
252
-0.1%
|
138.42
|
USD 34,881
|
|
2025-04-01 |
2025-03-31 |
PS
Planned sale
|
Chapman Steven Leonard
CEO AND PRESIDENT
Executive Director
|
9,311
-4.2%
138.41
USD 1,288,736
|
9,311
-4.2%
|
138.41
|
USD 1,288,736
|
|
2025-04-01 |
2025-03-31 |
PS
Planned sale
|
RABINOWITZ DANIEL
SEC. AND CHIEF LEGAL OFFICER
Officer
|
37
-0.0%
138.39
USD 5,120
|
37
-0.0%
|
138.39
|
USD 5,120
|
|
2025-04-01 |
2025-03-31 |
PS
Planned sale
|
RABINOWITZ DANIEL
SEC. AND CHIEF LEGAL OFFICER
Officer
|
1,367
-0.6%
138.41
USD 189,207
|
1,367
-0.6%
|
138.41
|
USD 189,207
|
|